Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 15/3/2021
SIETES contiene 93212 citas

<< anterior 21 a 40 de 306 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Anónimo. FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa. U.S. Food and Drug Administration 2015:16 de octubre. [Ref.ID 99566]
22.Tiene citas relacionadas Cita con resumen
Meltzer EO, Ratner PH, McGraw T. Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study. J Allergy Clin Immunol 2015;3:702-8. [Ref.ID 99480]
23.Enlace a cita original
Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, Sehgal N, Kuester J. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One 2015:14 de julio. [Ref.ID 99455]
24. Cita con resumen
Hawkes N. Modafinil does enhance cognition, review finds. BMJ 2015;351:h4573. [Ref.ID 99412]
25.Tiene citas relacionadas Cita con resumen
Dear JW, Antoine DJ, Park BK. Where are we now with paracetamol?. BMJ 2015;351:h3705. [Ref.ID 99251]
26. Cita con resumen
Anónimo. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. U.S. Food and Drug Administration 2014:1. [Ref.ID 98380]
27. Cita con resumen
Tan K, Petrie KJ, Faasse K, Bolland MJ, Grey A. Unhelpful information about adverse drug reactions. BMJ 2014;349:g5019. [Ref.ID 98190]
28. Cita con resumen
Anónimo. Another hepatitis C treatment recieves FDA approval. DIA Daily 2014:13 de octubre. [Ref.ID 98033]
29.Tiene citas relacionadas Cita con resumen
Torjesen I. Cochrane questions effectiveness of Tamiflu. BMJ 2014;348:g2675. [Ref.ID 97930]
30. Cita con resumen
Anónimo. Apremilast (Otezla) for psoriatic arthritis. Med Lett Drugs Ther 2014;56:41-2. [Ref.ID 97916]
31. Cita con resumen
Anónimo. FDA approves naloxegol for opioid-induced constipation. DIA Daily 2014:17 de septiembre. [Ref.ID 97910]
32. Cita con resumen
Anónimo. FDA approves new drug to treat a form of Gaucher disease. U.S. Food and Drug Administration 2014:19 de agosto. [Ref.ID 97855]
33. Cita con resumen
Anónimo. FDA approves Orbactiv to treat skin infections. U.S. Food and Drug Administration 2014:6 de agosto. [Ref.ID 97853]
34. Cita con resumen
Stokley S, Jeyarajah J, Yankey D, Yankey D, Gee J, Roark J, Curtis CR, Markowitz L. Human Papillomavirus Vaccination Coverage among Adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 — United States. Morbidity and Mortality Weekly Report 2014;63:620-4. [Ref.ID 97744]
35. Cita con resumen
Anónimo. Tasimelteon (Hetlioz) for non-24-hour sleep-wake disorder. Med Lett Drugs Ther 2014;56:34-5. [Ref.ID 97528]
36. Cita con resumen
Anónimo. Medicine to treat colitis, Crohn’s disease gets FDA nod. DIA Daily 2014:21 de mayo. [Ref.ID 97520]
37. Cita con resumen
Finegold JA, Manisti CH, Goldacre B, Barron AJ, Francis DP. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. European Journal of Preventive Cardiology 2014;21:464-74. [Ref.ID 97504]
38. Cita con resumen
Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Research 2014;216:67-73. [Ref.ID 97503]
39. Cita con resumen
Anónimo. Sofosbuvir (Sovaldi) for chronic hepatitis C. Med Lett Drugs Ther 2014;56:5-6. [Ref.ID 97219]
40. Cita con resumen
Vickers AJ, Linde K. Acupuncture for chronic pain. JAMA 2014;311:955-6. [Ref.ID 97198]
Seleccionar todas
<< anterior 21 a 40 de 306 siguiente >>